There’s a certain thrill when you land your first big client. A marquee name. Seven figures. Real validation. You

There are two types of pivots in startup life: the accidental kind, and the one you actually plan. The former

Picture this: a young biotech founder in Boston is pitching their company to a room full of investors. The founder

Startups rarely die all at once. They erode. Slowly. Through investor no’s, staff attrition, product-market ambiguity, and the general

Founders are usually excellent at preparing for success. They build spreadsheets full of upside scenarios, draw hockey-stick revenue projections with

Biotech startups are where some of the most groundbreaking ideas in science emerge. Yet their pitch decks often feel like

Decoding Investor Intent: It’s Not on the Website When it comes to raising capital, founders tend to be optimists—

How to Actually Find the Right Investors: A Field Guide for Biotech Founders In a previous post, I explained why

Somewhere between the lab bench and the pitch deck, a strange thing happens to many biotech founders. These are individuals

European biopharma is a maddening paradox. It has the academic firepower to generate groundbreaking discoveries but lacks the financial machinery